Food and Drug Policy Forum

FDLI's Food and Drug Policy Forum provides a marketplace for the exchange of policy ideas regarding food and drug law issues, and is complimentary to all FDLI Members. The Policy Forum articles are on cutting-edge state, national and international policy issues related to food and drug law.

The Policy Forum is published biweekly (24 times a year) and is provided as a complimentary benefit to FDLI members, and by subscription to members of associations on the Forum Editorial Advisory Board (listed below) and non-members. Individual issues of the Policy Forum are also available for separate purchase.



Food and Drug Policy Forum

Medical Device Tax and Innovation: The Last Nail?

May 2013

The current issue of Policy Forum (Volume 3, Number 9, May 22, 2013) – “The Medical Device Tax and Innovation: The Last Nail?...

In the Aftermath of Parens Patriae: Can Private Copycats Still Sue?

April 2013

This issue of our Policy Forum (Volume 3, Number 8, April 24, 2013) — In the Aftermath of Parens Patriae: Can Privat...

Substantial Equivalence Under the Family Smoking Prevention and Tobacco Control Act of 2009: How Can FDA Create a More Effective and Efficient Regulatory Scheme?

April 2013

(A Response to Mark E. Greenwold’s ‘What Standards Should FDA Apply in Ruling on Applications for Substantial Equivalence for...

Biosimilar Naming: How Do Adverse Event Reporting Data Support the Need for Distinct Non-Proprietary Names for Biosimilars?

March 2013

This issue of Policy Forum (Volume 3, Number 6, March 27, 2013) – Biosimilar Naming: How Do Adverse Event Reporting Data Suppo...

Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health?

March 2013

In this issue of our Policy Forum (Volume 3, Number 5, March 13, 2013) – Out on a Limb: How Will the Prohibition of Biomedical Rese...

Additional Policy Forum Details

The Policy Forum welcomes articles on cutting-edge state, national and international policy issues related to food and drug law. FDLI's Food and Drug Policy Forum is designed to provide a venue for the presentation of information, analysis and policy recommendations in these areas: food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

Each 10-page, peer-reviewed issue of the Policy Forum presents an important policy topic in the form of a question, provides background information and detailed discussion of the issues involved in the policy question, relevant research, pertinent sources and policy recommendations.

The 24-member Food and Drug Policy Forum Editorial Advisory Board, comprised of 8 representatives of leading associations interested in food and drug law issues and 16 individuals, provides peer review and guidance on articles considered for publication in the Forum.

  • American Enterprise Institute
  • Consumer Healthcare Products Association
  • Drug Information Association
  • International Dairy Foods Association
  • Medical Device Manufacturers Association
  • Personal Care Products Council
  • PhRMA
  • United Fresh Produce Association